×
About 29,203 results

Neurologic Stem Cell Treatment Study
https://clinicaltrials.gov/ct2/show/NCT02795052

Sep 10th, 2021 - Various clinical studies have registered with the National Institutes of Health (NIH) to study neurologic diseases and damage. There have also been a number of journal reports of the benefits of treatment with BMSC for diseases and damage to nervous tissue. The investigators hope to add to the volume of literature regarding the use of BMSC in those neurologic diseases and conditions identified ...

Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury
https://clinicaltrials.gov/ct2/show/NCT04493840

Sep 10th, 2021 - Shenfu injection is a traditional Chinese medicine formulation containing ginseng (Panax; family: Araliaceae) and aconite (Radix aconiti lateralis preparata, Aconitum carmichaeli Debx; family: Ranunculaceae) with Ginsenosides and aconite alkaloids as the main active ingredients. Its quality is strictly controlled in compliance with the standard of the China Ministry of Public Health (official a...

Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial
https://clinicaltrials.gov/ct2/show/NCT04310046

Sep 10th, 2021 - The prevalence of coronary artery disease in patients with severe aortic stenosis is high. About 30-60% of patients undergoing TAVI exhibit coexisting coronary artery disease. Optimal timing of coronary revascularization in patients with severe aortic stenosis and concomitant coronary artery disease undergoing TAVI is uncertain. The goal of this investigator-initiated, randomized, multicenter, ...

Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome
https://clinicaltrials.gov/ct2/show/NCT02520921

Sep 10th, 2021 - Patients who show high persistent platelet reactivity under aspirin are increasingly becoming an issue of clinical concern. Several studies have suggested that giving aspirin more frequently is very effective for reducing aspirin high persistent platelet reactivity, especially in diabetic patientsor in patients with a known risk factor. The aim of the study is to evaluate low dose of aspirin tw...

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease
https://clinicaltrials.gov/ct2/show/NCT04828590

Sep 10th, 2021 - Coronary artery disease (CAD) is the most common type of heart disease, and it is the leading cause of death worldwide in both men and women. CAD happens when the coronary arteries become hardened and narrowed, which is due to the buildup of cholesterol-containing deposits-plaque on the inner vessel wall. As the plaque grows, less blood can flow through the arteries due to the vessel narrowing....

MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial
https://clinicaltrials.gov/ct2/show/NCT03135275

Sep 10th, 2021 - An investigator-initiated, randomized, multicenter, two-arm, open-label study of consecutive patients presenting with STEMI and MVD in stable hemodynamic conditions, undergoing after successful PCI of the culprit lesion either (1:1 randomization) immediate revascularization of all additional target lesions during the index procedure or staged PCI of all additional target lesions (within 19 to 4...

Magnetic Resonance Imaging In Acute ST-Elevation Myocardial Infarction
https://clinicaltrials.gov/ct2/show/NCT04113356

Sep 10th, 2021 - Cardiovascular magnetic resonance imaging enables comprehensive assessment of cardiovascular function, morphology and pathology. The investigators aim to evaluate the nature and clinical significance of magnetic resonance imaging parameters in patients presenting with first acute ST-elevation myocardial infarction.

Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study
https://clinicaltrials.gov/ct2/show/NCT03225625

Sep 10th, 2021 - The Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality (SciExVR) study is based on the progress that researchers have made treating spinal cord injury (SCI) with bone marrow derived stem cells (BMSC). While major improvements have remained elusive with other approaches, modest benefits have been achieved. The use of subarachnoid BMSC provided via intrathecal injection has resulted in ...

Effects of Homocysteine in Myocardial Infarction Patients in a Tertiary Care Hospital of Pakistan
https://clinicaltrials.gov/ct2/show/NCT05011032

Sep 10th, 2021 - Excess of low density lipoproteins, high blood pressure, obesity, excess of blood sugar levels, smoking and sedentary life style are the known modifiable risk factors causing cardiovascular disease specifically Coronary disease. There can be some other substances which can additionally affect the human cardiac physiology as well i.e. high levels of Homocysteine molecule in the blood. The advers...

Craniectomy Protocol
https://clinicaltrials.gov/ct2/show/NCT01990014

Sep 10th, 2021 - The objective of this protocol is to evaluate the quality of life and functional disability in the long term (2 years after craniectomy) in subject's victims of malignant Sylvien stroke who received a decompressive craniotomy in the acute phase. Patients who have given their consent to be evaluated at least two years after their stroke and their operation in a single visit by clinical examinati...

Rota China Registry
https://clinicaltrials.gov/ct2/show/NCT03806621

Sep 10th, 2021 - Rotational atherectomy (RA) facilitates percutaneous coronary intervention for complex de novo lesions with severe calcification. Some observational studies and a small randomized trial indicated that a strategy of routine RA did not conferred reduction in restenosis or MACE, but these studies are limited by missing follow-up, insufficient power to compare outcomes, and confounding factors in t...

HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in MI Patients
https://clinicaltrials.gov/ct2/show/NCT05024864

Sep 10th, 2021 - Background: Despite progressively reduced mortality over the last decades, cardiovascular disease remains the most common cause of death in both men and women in Sweden and the world. Ischemic heart disease with its acute presentation myocardial infarction (MI) accounts for the majority of cases, approximately 25000 hospitalized patients in Sweden annually. In addition to early revascularizatio...

Neural Interfaces to Monitor Fatigue and Sleepiness in the Cathlab
https://clinicaltrials.gov/ct2/show/NCT05041218

Sep 10th, 2021 - The investigators will prospectively record and analyze Electroencephalogram (EEG) signals from 5 interventional cardiologists and 2 fellows in training in all consecutive procedures at Ferrara University Hospital. Considering the hypothesis of independence of the working shifts, given the heterogeneity of their structure in terms of procedures' number and type and their distance in time, it is...

Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz
https://clinicaltrials.gov/ct2/show/NCT05041010

Sep 10th, 2021 - Neu2000 was designed as a multi-target neuroprotectant preventing both the NMDA receptor, a Ca2+ -permeable glutamate receptor, and free radicals, two major routes of brain cell death in stroke. Neu2000 is a moderate NR2B-selective NMDA receptor antagonist and spin trapping molecule (=free radical scavenger or antioxidant). Therapeutic potential of Neu2000 has been well demonstrated in four ani...

Experience of Relatives and Intensive Care Units Caregivers of Controlled Donation After Circulatory Death
https://clinicaltrials.gov/ct2/show/NCT05041023

Sep 10th, 2021 - While withdrawal of life-sustaining therapies (WLST) decision occur significantly more frequently in intensive care units (ICUs), controlled donation after circulatory death (cDCD) evolves end-of-life care and produces a new end-of-life (EOL) model: EOL care now includes the opportunity to donate organs and tissues after death. During cDCD, the patient is still alive while OD process is being d...

Identification of Risk Factors for the Occurrence of High-grade Rhythm Disorders in Patients With ST-segment Elevation Myocardial Infarction (STEMI)
https://clinicaltrials.gov/ct2/show/NCT05040919

Sep 10th, 2021 - The goal of this study is to identify the risk factors for the occurrence of arrythmia in patient with stemi in prehospital management. We included 652 patients who presenting a STEMI from september 2017 to october 2020 and manage by physician in prehospital and bring to CHU of Dijon. We analyse and compare the caracteristics of a group of STEMI patients who presenting an arrythmia to an other ...

Controlled Level EVERolimus in Acute Coronary Syndromes
https://clinicaltrials.gov/ct2/show/NCT01529554

Sep 10th, 2021 - Acute myocardial infarction (AMI) constitutes the major cause of death in most nations and death rates and morbidity remain substantial in the years thereafter. Inflammation is a hallmark throughout the distinct stages of atherosclerotic lesion formation preceding AMI as well as at the time of plaque rupture and during the post-infarct repair phase. Harnessing its harmful consequences constitut...

Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry
https://clinicaltrials.gov/ct2/show/NCT04279496

Sep 10th, 2021 - CONFIRM2 is a retrospective and prospective, open-label, international, multicenter observational registry designed to evaluate associations between CCTA imaging findings and clinical presentation (cross-sectional) and their ability to predict mortality and major adverse cardiac events (longitudinal) in patients with chronic CAD.

A Prospective Study of Fractional Flow Reserve Assessment of Intermediate Coronary Stenoses in Severe Aortic Stenosis
https://clinicaltrials.gov/ct2/show/NCT03442400

Sep 9th, 2021 - The purpose of the study is to determine whether iFR assessment gives a valid assessment of coronary hemodynamics in patients with severe aortic stenosis. Several factors confound the interpretation of fractional flow reserve (FFR) in patients with severe aortic stenosis (AS) and intermediate severity coronary stenoses, and the widely accepted cut-off value of 0.80 may not be applicable to this...

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
https://clinicaltrials.gov/ct2/show/NCT01130519

Sep 9th, 2021 - Background: Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is a familial cancer syndrome characterized by a propensity for developing renal cancer, uterine and cutaneous leiomyomas.The kidney cancer associated with HLRCC is associated with HLRCC is clinically aggressive and is characterized by unique histopathologic features that are sometimes described as type2 papillary RCC. Germline...